Donald E. Bobo Jr. - 08 Jul 2022 Form 4 Insider Report for Edwards Lifesciences Corp (EW)

Role
CVP,Strategy/Corp Development
Signature
Linda J. Park, Attorney-in-Fact
Issuer symbol
EW
Transactions as of
08 Jul 2022
Net transactions value
-$419,662
Form type
4
Filing time
08 Jul 2022, 18:21:05 UTC
Previous filing
13 Jun 2022
Next filing
09 Aug 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EW Common Stock Options Exercise $236,698 +6,725 +11% $35.20 69,286 08 Jul 2022 Direct F1
transaction EW Common Stock Sale $656,360 -6,725 -9.7% $97.60 62,561 08 Jul 2022 Direct F1
holding EW Common Stock 38,267 08 Jul 2022 401(k) F2
holding EW Common Stock 117,320 08 Jul 2022 By Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EW Employee Stock Option (Right to Acquire) Options Exercise $0 -6,725 -10% $0.000000 60,525 08 Jul 2022 Common Stock 6,725 $35.20 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 25, 2022.
F2 Reflects shares represented on the most recent statement of the Issuer's 401(k) Plan Administrator.

Remarks:

This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the reporting person.